Miguel Ángel Ma Calleja-Hernández (Miguel Ángel Calleja, Miguel Ángel Calleja-Hernández, Miguel Ángel Calleja, M A Calleja, Miguel Á Calleja-Hernández)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Hidradenitis Suppurativa

Top Venues

Applied health economics and health policy

Acta oncologica (Stockholm, Sweden)

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Maurício Francis Abdalla, Benito Cadenas-Noreña, Miguel Ángel Ma Calleja-Hernández, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrandiz, Juan Oliva, José Luis Trillo, Álvaro Hidalgo-Vega
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries. Applied health economics and health policy (2024)
Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Maurício Francis Abdalla, Benito Cadenas-Noreña, Miguel Ángel Ma Calleja-Hernández, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrandiz, Juan Oliva, José Luis Trillo, Álvaro Hidalgo-Vega
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries. Applied health economics and health policy 22 (3) (2024)
Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Maurício Francis Abdalla, Benito Cadenas-Noreña, Miguel Ángel Ma Calleja-Hernández, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrandiz, Juan Oliva, José Luis Trillo, Álvaro Hidalgo-Vega
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries. Applied health economics and health policy 22 (3) (2024)
Miguel Ángel Ma Calleja-Hernández, Andrés Navarro, José María Serratosa, Manuel Toledo, Vicente Villanueva, Silvia Subías Labazuy, Alicia Gil
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain. Expert review of pharmacoeconomics & outcomes research 22 (7) (2022)
Marta M Valera-Rubio, María Isabel Mi Sierra-Torres, Raquel R Castillejo García, Jaime J Cordero-Ramos, María Reyes Mr López-Márquez, Óscar O Cruz-Salgado, Miguel Ángel Ma Calleja-Hernández
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital. Expert review of vaccines 21 (4) (2022)
Néboa Zozaya, Javier Villaseca, Fernando Maurício Francis Abdalla, Miguel Ángel Ma Calleja-Hernández, José Luis Díez-Martín, J Estévez, Miriam Santero, Joaquin Martinez Lopez, J Sierra, Ruth Vera, Álvaro Hidalgo-Vega
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (6) (2022)
Jaime J Cordero-Ramos, Rubén Barros-Tornay, Tomás Toledo-Pastrana, Lara Ferrándiz, Miguel Ángel Ma Calleja-Hernández, David Moreno-Ramírez
Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study. The Journal of dermatology 49 (4) (2022)
María Elena Cárdaba García, Encarnación Abad-Lecha, Miguel Ángel Ma Calleja-Hernández
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment. The Libyan journal of medicine 16 (1) (2021)
Ricardo García-Fumero, Cristina Fernández-López, Miguel Ángel Ma Calleja-Hernández, José Expósito-Hernández
Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1. Acta oncologica (Stockholm, Sweden) 60 (9) (2021)